NeOnc Research Development from 2010 to 2026

NTHI Stock   9.13  0.23  2.58%   
NeOnc Technologies' Research Development is increasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 1.8 M. For the period between 2010 and 2026, NeOnc Technologies, Research Development quarterly trend regression had mean deviation of  634,186 and range of 2.8 M. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
3.5 M
Current Value
1.8 M
Quarterly Volatility
878.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check NeOnc Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NeOnc Technologies' main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 3.1 M or Total Revenue of 100.2 K, as well as many indicators such as . NeOnc financial statements analysis is a perfect complement when working with NeOnc Technologies Valuation or Volatility modules.
  
Build AI portfolio with NeOnc Stock
Check out the analysis of NeOnc Technologies Correlation against competitors.

Latest NeOnc Technologies' Research Development Growth Pattern

Below is the plot of the Research Development of NeOnc Technologies Holdings over the last few years. It is NeOnc Technologies' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NeOnc Technologies' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

NeOnc Research Development Regression Statistics

Arithmetic Mean1,123,773
Geometric Mean931,286
Coefficient Of Variation78.18
Mean Deviation634,186
Median674,558
Standard Deviation878,579
Sample Variance771.9B
Range2.8M
R-Value0.69
Mean Square Error431.2B
R-Squared0.48
Significance0
Slope120,075
Total Sum of Squares12.4T

NeOnc Research Development History

20261.8 M
20253.5 M
2024M
20231.5 M
20221.2 M

About NeOnc Technologies Financial Statements

Investors use fundamental indicators, such as NeOnc Technologies' Research Development, to determine how well the company is positioned to perform in the future. Although NeOnc Technologies' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development3.5 M1.8 M

Currently Active Assets on Macroaxis

When determining whether NeOnc Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeOnc Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neonc Technologies Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neonc Technologies Holdings Stock:
Check out the analysis of NeOnc Technologies Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeOnc Technologies. If investors know NeOnc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeOnc Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.47)
Revenue Per Share
0.005
Quarterly Revenue Growth
(0.07)
The market value of NeOnc Technologies is measured differently than its book value, which is the value of NeOnc that is recorded on the company's balance sheet. Investors also form their own opinion of NeOnc Technologies' value that differs from its market value or its book value, called intrinsic value, which is NeOnc Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeOnc Technologies' market value can be influenced by many factors that don't directly affect NeOnc Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeOnc Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeOnc Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeOnc Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.